A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

Giant cell arteritis is a systemic vasculitis and careful attention should be given to the examination of the cardiovascular system including performing blood pressure measurements in both arms.

Mortality rates among patients with GCA in Spain are similar to that of the general population, with older age and male sex linked to higher mortality.

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release ...

Objectives Granulocyte-macrophage colony-stimulating factor (GM-CSF) is implicated in pathogenesis of giant cell arteritis. We evaluated the efficacy of the GM-CSF receptor antagonist mavrilimumab in ...

The limitations of corticosteroids in the treatment of some cases of GCA have led to the evaluation of other strategies using steroid sparing agents. 4– 7 In two previous studies patients with ...

Giant cell arteritis (GCA) is a chronic systemic vasculitis affecting large-sized and medium-sized vessels. Glucocorticoids are currently the mainstay of treatment for GCA and associated large vessel ...

On the eve of the EFM Screen has learned that US distributor Giant Pictures is launching an international sales division. Giant Pictures general manager, Nick Savva, Tom Bairstow formerly of Sony ...

On the eve of the EFM Screen has learned that US distributor Giant Pictures is launching an international sales division. Giant Pictures general manager, Nick Savva, Tom Bairstow formerly of Sony ...